NCT00509210View on ClinicalTrials.gov

Study of Telaprevir in Subjects With Hepatic Impairment

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Hepatic Insufficiency
Interventions
DRUG

telaprevir (VX-950)

Trial Locations (1)

46202

Indiana University, Department of Medicine,Division of Gastroenterology / Hepatology, Indianapolis

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT00509210 - Study of Telaprevir in Subjects With Hepatic Impairment | Biotech Hunter | Biotech Hunter